Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents
SALT LAKE CITY, Nov. 20, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced it has delivered results to one million consumers with its SneakPeek® Early Gender DNA Test. Since 2015, SneakPeek has been providing expectant families with an easy and convenient way to learn the sex of their baby as early as six weeks into pregnancy.
Related news for (MYGN)
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/06/25 08:00 AM
- Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum
- Breaking News: MoBot’s Latest Update as of 08/05/25 04:00 PM
- 24/7 Market News Snapshot 05 August, 2025 – Myriad Genetics Inc (NASDAQ:MYGN)
- Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen